Jeffrey Scott Riley, CEO and President at Synthetic Biologics, Inc. (SYN), bought 2,000 shares at $1.71 ($3K) on 2013-01-03, disclosed to the SEC on 2013-01-04.
Open-market purchase of $3k SYN by CEO and President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| SYN | BUY | 2013-01-03 | $10K | — | Filing → |